Acoramidis may improve cardiac mass, function in transthyretin amyloid cardiomyopathy
ATLANTA — Data from a small substudy with cardiac MRI suggest acoramidis may improve both cardiac mass and function for adults with symptomatic transthyretin amyloid cardiomyopathy, building on previous positive data, researchers reported.The findings were presented at the American College of Cardiology Scientific Session.